{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:46:30Z","timestamp":1767840390182,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00595-021-02263-z","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T19:38:11Z","timestamp":1616096291000},"page":"1361-1370","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Invasive pulmonary aspergillosis after liver transplantation: lessons from successfully treated cases and review of the literature"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1138-7437","authenticated-orcid":false,"given":"Kodai","family":"Abe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Shinoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Uno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Obara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Kitago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Hishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,18]]},"reference":[{"issue":"2","key":"2263_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00005792-199903000-00003","volume":"78","author":"DL Paterson","year":"1999","unstructured":"Paterson DL, Singh N. Invasive aspergillosis in transplant recipients. Medicine. 1999;78(2):123\u201338.","journal-title":"Medicine"},{"issue":"2","key":"2263_CR2","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/lt.24032","volume":"21","author":"F Barchiesi","year":"2015","unstructured":"Barchiesi F, Mazzocato S, Mazzanti S, Gesuita R, Skrami E, Fiorentini A, et al. Invasive aspergillosis in liver transplant recipients: epidemiology, clinical characteristics, treatment, and outcomes in 116 cases. Liver Transpl. 2015;21(2):204\u201312.","journal-title":"Liver Transpl"},{"issue":"6","key":"2263_CR3","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/lt.20365","volume":"11","author":"WC Hellinger","year":"2005","unstructured":"Hellinger WC, Bonatti H, Yao JD, Alvarez S, Brumble LM, Keating MR, et al. Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation. Liver Transpl. 2005;11(6):656\u201362.","journal-title":"Liver Transpl"},{"key":"2263_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ctr.13544","volume":"33","author":"S Husain","year":"2019","unstructured":"Husain S, Camargo JF. Invasive Aspergillosis in solid-organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transpl. 2019;33:1\u201324.","journal-title":"Clin Transpl"},{"issue":"4","key":"2263_CR5","doi-asserted-by":"publisher","first-page":"e454","DOI":"10.1111\/ctr.12129","volume":"27","author":"F Saliba","year":"2013","unstructured":"Saliba F, Delvart V, Ichai P, et al. Fungal infections after liver transplantation: outcomes and risk factors revisited in the MELD era. Clin Transplant. 2013;27(4):e454\u201361.","journal-title":"Clin Transplant"},{"issue":"2","key":"2263_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jiac.2015.11.005","volume":"22","author":"M Nagao","year":"2016","unstructured":"Nagao M, Fujimoto Y, Yamamoto M, Matsumura Y, Kaido T, Takakura S, et al. Epidemiology of invasive fungal infections after liver transplantation and the risk factors of late-onset invasive aspergillosis. J Infect Chemother. 2016;22(2):84\u20139.","journal-title":"J Infect Chemother"},{"key":"2263_CR7","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/lt.21099","volume":"13","author":"M Osawa","year":"2007","unstructured":"Osawa M, Ito Y, Hirai T, Isozumi R, Takakura S, Fujimoto Y, et al. Risk factors for invasive aspergillosis in living donor liver transplant recipients. Liver Transpl. 2007;13:566\u201370.","journal-title":"Liver Transpl"},{"key":"2263_CR8","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s00534-011-0423-4","volume":"19","author":"T Ohkubo","year":"2012","unstructured":"Ohkubo T, Sugawara Y, Takayama T, Kokudo N, Makuuchi M. The risk factors of fungal infection in living-donor liver transplantations. J Hepatobiliary Pancreat Sci. 2012;19:382\u20138.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"9","key":"2263_CR9","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.3201\/eid2009.140142","volume":"20","author":"CD Pham","year":"2014","unstructured":"Pham CD, Reiss E, Hagen F, Meis JF, Lockhart SR. Passive surveillance for azole-resistant Aspergillus fumigatus, United States, 2011\u20132013. Emerg Infect Dis. 2014;20(9):1498\u2013503.","journal-title":"Emerg Infect Dis"},{"key":"2263_CR10","first-page":"173","volume-title":"The guidelines for management of deep-seated mycoses","author":"S Kohno","year":"2014","unstructured":"Kohno S. The guidelines for management of deep-seated mycoses. Tokyo: Kyowa Kikaku; 2014. p. 173\u201381."},{"key":"2263_CR11","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1093\/cid\/ciw444","volume":"63","author":"TF Patterson","year":"2016","unstructured":"Patterson TF, Thompson GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice guidelines for the diagnosis and management of Aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63:e26\u20137.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2263_CR12","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S0022-5223(95)70202-4","volume":"109","author":"L Robinson","year":"1995","unstructured":"Robinson L, Reed E, Galbraith T, Alonso A, Moulton AL, Fleming WH, et al. Pulmonary resection for invasive Aspergillus infections in immunocompromised patients. J Thorac Cardiovasc Surg. 1995;109(6):1182\u201397.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"10","key":"2263_CR13","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1016\/j.transproceed.2007.05.085","volume":"39","author":"K Takeda","year":"2007","unstructured":"Takeda K, Morioka D, Matsuo K, Endo I, Sekido H, Moroboshi T, et al. A case of successful resection after long-term medical treatment of invasive pulmonary aspergillosis following living donor liver transplantation. Transplant Proc. 2007;39(10):3505\u20138.","journal-title":"Transplant Proc"},{"key":"2263_CR14","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/j.1872-034X.2011.00860.x","volume":"41","author":"S Mochida","year":"2011","unstructured":"Mochida S, Takikawa Y, Nakayama N, Oketani M, Naiki T, Yamagishi Y, et al. Diagnostic criteria of acute liver failure: a report by the Intractable Hepato-Biliary Diseases. Study group of Japan. Hepatol Res. 2011;41:805\u201312.","journal-title":"Hepatol Res"},{"key":"2263_CR15","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00535-012-0624-x","volume":"47","author":"K Sugawara","year":"2012","unstructured":"Sugawara K, Nakayama N, Mochida S. Acute liver failure in Japan: definition, classification, and prediction of the outcome. J Gastroenterol. 2012;47:849\u201361.","journal-title":"J Gastroenterol"},{"key":"2263_CR16","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"BD Pauw","year":"2008","unstructured":"Pauw BD, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer\/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC\/MSG) consensus group. Clin Infect Dis. 2008;46:1813\u201321.","journal-title":"Clin Infect Dis"},{"key":"2263_CR17","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.transproceed.2012.01.139","volume":"44","author":"M Shinoda","year":"2012","unstructured":"Shinoda M, Tanabe M, Kawachi S, Ono Y, Hayakawa T, Iketani O, et al. Pharmacokinetics of mizoribine in adult living donor liver transplantation. Transplant Proc. 2012;44:1329\u201335.","journal-title":"Transplant Proc"},{"key":"2263_CR18","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/j.1365-2362.2010.02339.x","volume":"40","author":"M Tanabe","year":"2010","unstructured":"Tanabe M, Kawachi S, Obara H, Shinoda M, Hibi T, Kitagawa Y, et al. Current progress in ABO-incompatible liver transplantation. Eur J Clin Investig. 2010;40:943\u20139.","journal-title":"Eur J Clin Investig"},{"issue":"9","key":"2263_CR19","doi-asserted-by":"publisher","first-page":"e00970","DOI":"10.1128\/AAC.00970-17","volume":"61","author":"RM Rivosecchi","year":"2017","unstructured":"Rivosecchi RM, Clancy CJ, Shields RK, Ensor CR, Shullo MA, Falcione BA, et al. Effects of isavuconazole on the plasma concentrations of tacrolimus among solid-organ transplant patients. Antimicrob Agents Chemother. 2017;61(9):e00970-e1017. https:\/\/doi.org\/10.1128\/AAC.00970-17.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2263_CR20","first-page":"76","volume":"6","author":"AH Groll","year":"2017","unstructured":"Groll AH, Desai A, Han D, Howieson C, Kato K, Akhtar S, et al. Pharmacokinetic Assessment of drug-drug interactions of isavuconazole with the immunosuppressants cyclosporine, mycophenolic acid, prednisolone, sirolimus, and tacrolimus in healthy adults. Clin Pharmacol Ther. 2017;6(1):76\u201385.","journal-title":"Clin Pharmacol Ther"},{"key":"2263_CR21","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1053\/jlts.2002.36239","volume":"8","author":"J Furtun","year":"2002","unstructured":"Furtun J, Martin-Davila P, Moreno S, Vicente ED, Nu\u00f1o J, Candelas A, et al. Risk factors for invasive aspergillosis in liver transplant recipients. Liver Transpl. 2002;8:1065\u201370.","journal-title":"Liver Transpl"},{"issue":"9","key":"2263_CR22","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/hepr.13364","volume":"49","author":"K Umeshita","year":"2019","unstructured":"Umeshita K, Eguchi S, Egawa H, Haga H, Kasahara M, Kokudo N, et al. Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society. Hepatol Res. 2019;49(9):964\u201380.","journal-title":"Hepatol Res"},{"issue":"6","key":"2263_CR23","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJMoa020191","volume":"347","author":"R Herbrecht","year":"2002","unstructured":"Herbrecht R, Denning D, Patterson T, Bennett JE, Greene RE, Oestmann JW, et al. Voricanozole versus amphotericin B for primary therapy of invasive Aspergillosis. N Engl J Med. 2002;347(6):408\u201315.","journal-title":"N Engl J Med"},{"issue":"9","key":"2263_CR24","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1093\/jac\/dkz258","volume":"74","author":"A Resendiz-Sharpe","year":"2019","unstructured":"Resendiz-Sharpe A, Mercier T, Lestrade PPA, van der Beek MT, von dem Borne PA, Cornelissen JJ, et al. Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients. J Antimicrob Chemother. 2019;74(9):2759\u201366.","journal-title":"J Antimicrob Chemother"},{"issue":"55","key":"2263_CR25","first-page":"1","volume":"5","author":"SM Rudramurthy","year":"2019","unstructured":"Rudramurthy SM, Paul RA, Chakrabarti A, Mouton JW, Meis JF. Invasive Aspergillosis by Aspergillus flavus: epidemiology, diagnosis, antifungal resistance, and management. J Fungi. 2019;5(55):1\u201323.","journal-title":"J Fungi"},{"issue":"8","key":"2263_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.02583-16","volume":"61","author":"A Hashimoto","year":"2017","unstructured":"Hashimoto A, Hagiwara D, Watanabe A, Yahiro M, Yikelamu A, Yaguchi T, et al. Drug Sensitivity and resistance mechanism in Aspergillus section Nigri strains from Japan. Antimicrob Agents Chemother. 2017;61(8):1\u201310.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2263_CR27","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/ped.13193","volume":"59","author":"N Tetsuka","year":"2017","unstructured":"Tetsuka N, Yaguchi T, Machida H, Ito S, Miyairi I. Invasive pulmonary aspergillosis due to azole-resistant Aspergillus lentulus. Pediatr Int. 2017;59(3):362\u20133.","journal-title":"Pediatr Int"},{"key":"2263_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cmi.2018.01.002","volume":"24","author":"AJ Ullmann","year":"2018","unstructured":"Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, et al. Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clin Microbiol Infect. 2018;24:1\u201338.","journal-title":"Clin Microbiol Infect"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-021-02263-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00595-021-02263-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-021-02263-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T17:04:29Z","timestamp":1626541469000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00595-021-02263-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,18]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["2263"],"URL":"https:\/\/doi.org\/10.1007\/s00595-021-02263-z","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,18]]},"assertion":[{"value":"11 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are some conflicts of interest to declare: Masahiro Shinoda, Eisai Co., Ltd and Taiho pharmaceutical Co., Ltd; Yuko Kitagawa, ONO PHARMACEUTICAL CO., LTD., Bristol-Myers Squibb, Olympus Corporation, AsahiKASEI Co., Ltd., TAIHO PHARMACEUTICAL CO., LTD., CHUGAI PHARMACEUTICAL CO., LTD., Otsuka Pharmaceutical Co., Ltd., TSUMURA & CO., Takeda Pharmaceutical Co., Ltd., MEDICON INC., Yakult Honsha Co., Ltd., EA Pharma Co. Ltd., Eisai Co. Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}